Fifth Third Bancorp’s Sutro Biopharma STRO Stock Holding History

Fifth Third Bancorp’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66	Hold	2	–	–	﹤0.01%	4312
2026 Q1	$50	Buy	+2	New	+$36	﹤0.01%	4279

Other funds holding STRO

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Fifth Third Bancorp's STRO Position: Q2 2026 in Review

Fifth Third Bancorp held its Sutro Biopharma (STRO) position steady in Q2 2026 at 2 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #4312.

Fifth Third Bancorp first reported a position in STRO in Q1 2026 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

Fifth Third Bancorp held 2 shares of Sutro Biopharma worth $66 as of Q2 2026.
Fifth Third Bancorp left its Sutro Biopharma share count unchanged in Q2 2026.
Sutro Biopharma made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4312 holding.
Fifth Third Bancorp first reported a position in Sutro Biopharma in Q1 2026 and has held it in 2 quarters since.
100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.